News 
Market Data 
Discover
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
LOOK as to how this SGLN PR is written:
SurgLine Implants Saturday, 05/30/15 09:46:24 AM
Re: None
Post # of 71944
SurgLine International receives letter from the SEC which closes it investigation against the Company as of May 29 2015
Newport Beach, California -- May 30, 2015 / (http://www.myprgenie.com) -- For Immediate Release For Further Information Contact:
May 29, 2015 Thomas Toland
949-698-8485 mobile
SURGLINE INTERNATIONAL, UPDATE on receiving its letter closing the investigation against the Company without enforcement action
WEST PALM BEACH, Fla. May 29, 2015 SurgLine International, Inc. (SGLN.PK)
SurgLine International, Inc. received a letter today from The United States Securities and Exchange Commission ("SEC") San Francisco Regional Office which closed its investigation against the company.
The letter stated that had not recommended enforcement against the company as of May 29 2015.
The CEO, Mr. Toland was pleased that the investigation had come to its conclusion without enforcement of any type at this date and that this brought to conclusion the long awaited chapter in the company's history commenced in the fall of 2012.
Mr. Toland was quoted as saying, "The Company fully cooperated with the Commission on this investigation and always held that it had not knowingly violated any terms or conditions that would have warranted this voluntary action in the fall of 2012."
Forward Looking Statements
This update release may contain forward-looking statements, including information about management’s view of future expectations, plans and prospects for SurgLine International, Inc. (the "Company"). In particular, when used in the preceding discussion, the words "predicts", "believes", "expects", "intends", "seeks", "estimates", "plans", "anticipates", and similar conditional expressions or future or conditional verbs such as "will", "may", "might", "should" "would" and "could" are intended to identify forward-looking statements. In addition, our representatives may from time to time make oral forward-looking statements. Any such statements, other than those of historical fact, about an action, event or development are forward-looking statements. Such statements are based on the current expectations and certain assumptions of the Company’s management. Such statements are, therefore, subject to a variety of known and unknown risks, uncertainties, and other factors, many of which are beyond the control of the Company, which could cause the actual results, performance, its subsidiaries and concepts to be materially different than those that may be expressed or implied in such statements or anticipated on the basis of historical trends. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, the Company’s actual results, performance or achievements may vary materially from those described in the relevant forward-looking statements as bine expected, anticipated, intended, planned, believed, sought, estimated or projected. Unknown or unpredictable factors also could have material adverse effects on the Company’s future results. The forward-looking statements included herein are made only as of the date hereof. The company cannot guarantee future results, levels of activity, performance or achievements. Accordingly, you should not place undue reliance on these forward-looking statements. Finally, the company undertakes no obligation to update or revise these forward-looking statements to reflect the impact of circumstances or events that arise after the date of the forward-looking statement was made, except as required by law, and also takes no obligation to update or correct information prepared by third parties that re not paid for by the Company. You should not place undue reliance on any forward-looking statement and should consider the uncertainties and risks discussed under item, "Risk Factors" of the Company’s annual Report on Form 10-K for the year ended July 31, 2014 and in any of the Company’s other subsequent Securities and Exchange Commission filings.
Contact: Tom Toland, tom.toland2011@gmail.com, 949 698 8485
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=114149167
|
Followers
|
270
|
Posters
|
|
|
Posts (Today)
|
0
|
Posts (Total)
|
72077
|
|
Created
|
04/29/05
|
Type
|
Free
|
| Moderators | |||
SurgLine International, Inc., a premiere reseller and distributor of FDA approved stable technology for surgical implants and surgical instruments in the operating room, has executed a seller participation agreement on March 20, 2013 with MedPassage Inc. (medpassage.com) as a charter member of the MedPassage ecosystem. The Company will offer its full line of products that it sells to ambulatory surgery centers and hospitals through its affiliation with MedPassage at tremendous savings.
"The MedPassage ecosystem empowers medical centers and device companies to collaborate and exchange products more efficiently than ever before", said Tom Toland, CEO of SurgLine International, Inc. "We are pleased to work alongside MedPassage and their talented executive management team and are anticipating a tremendous opportunity for SurgLine and its product offering."
Over the coming weeks and months, SurgLine and MedPassage will work closely to load its catalogs of FDA approved cost-effective surgical products onto the MedPassage ecosystem for sale to surgery centers, hospitals, Accountable Care Organizations and Physician Owned Distributors also known as POD's.
At SurgLine, we believe that the ability to level the playing field for both buyers and sellers of medical devices and medical and surgical products will be the way of the future, and SurgLine will be right there leading the way with MedPassage.com.
About SurgLine, Inc.
SurgLine (www.surgline.com) sources and distributes high quality FDA approved medical and surgical products at discount prices, thereby reducing or eliminating the historical brand premium paid by healthcare providers including acute care hospitals, surgery centers, surgical hospitals, self-insured employers and insurance companies.
About SurgLine International, Inc.
SurgLine International, Inc. is a holding company that, in addition to SurgLine, wholly owns Nuvo Solar Energy, Inc.
This press release may include forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These statements are based on the Company's current expectations as to future events. However, the forward-looking events and circumstances discussed in this press release might not occur, and actual results could differ materially from those anticipated or implied in the forward-looking statements.
For Further Information Contact:
Thomas Toland
949-698-8485
 "More Value for your healthcare dollar." SURGLINE ALSO FORECAST'S OVER $10,000,000 IN REVENUES! China Nuvo Solar Energy, Inc. (OTCQB: CNUV) today announced that SurgLine, Inc. ("SurgLine") and one of its previously announced stocking distributors, OptiMedical Corp. ("OptiMedical") is in the final stages of completing a multi-million dollar order and as a result has revised its forecast to be in excess of $10 million by the end of 2012. Additionally, the Company is negotiating with other stocking distributors and channel sales agreements with third parties regarding additional sales and distribution of the Company's product line.
For ALL SEC Filings: Interwest Transfer Company, Inc., http://sec.gov/cgi-bin/browse-edgar?company=&CIK=0001126411&action=getcompany
*1. THE 19.1% PARTNERSHIP WITH MD CAPITAL ADVISORS **2. THE 19.1% PARTNERSHIP WITH CORE WINNER HOLDINGS OWNED BY ERIC SIU...A GIANT IN THE MEDICAL PRODUCT INDUSTRY We will be obtaining products through a sourcing and manufacturing relationship with Core Winner Holdings, LTD. ("Core winner"). Core Winner, based out of China, and holds approximately 19.1% of our common stock. The beneficial owner of Core Winner is Eric Siu. FOLLOW THE DD... Eric Siu graduated with honors from London University, UCL, Mathematics. He has over twenty years of management experience in in high-growth, international medical businesses. His experience includes medical product procurement and healthcare supply chain operations in China, medical product manufacturing in Germany and China, medical product distribution in the US. Eric is a health care thought leader in China. He was instrumental in introducing MIS (minimally invasive surgery) best practices into the PRC, and sold China's first laparscope tower to China's leadership healthcare unit, PLA Hospital 301. Eric also organized over 200 CME programs in conjunction with the Chinese Ministry of Health and international medical device manufacturers for Chinese surgeons. He is a medical consultant and director of two leading hospitals in China, and in 2009, one of Eric's companies was voted 7th most trusted medical company in China and one of the top 20 medical brands in China*. Eric's medical optics manufacturing company is one of the world's leading manufacturers of specialty surgical optics, and he has an exclusive partnership agreement with the world's largest radiotherapy company, Varian Medical Systems, to market its Proton System in China. Eric also has extensive technology, operations and product development with German-based companies. Eric's German company works with over 100 medical manufacturing customers ERIC ALSO OWNS A COMPANY CALLED ASIA WEST CAPITAL PARTNERS WHO JUST ON AUG 19TH SIGNED A STRATEGIC ALLIANCE WITH OUR OTHER 19.1% PARTNER MD CAPITAL ADVISORS. 
VA HOSITAL! Surg offers an entire portfolio of leading and innovative products that address every indication. Surg products leverage proven designs and are packaged as universal and all-in-one solutions - all available from one company. All Surg products are FDA approved and are manufactured in ISO certified facilities. Where required by the FDA, products are manufactured in FDA certified facilities. SurgLine currently offers the following products:
ENDOSCOPE PRODUCTS:
MEDICAL DISPOSABLES:
MORE ON SURGLINE! About SurgLine, Inc. SurgLine (www.surgline.com) sources and distributes high quality medical products at discount prices, thereby reducing the historical brand premium paid by healthcare providers. SurgLine offers medical and surgical supplies and products at substantial savings through stocking distributors and institutional buyers by sourcing products globally without the historical brand premium and industry markup. SurgLine's management team is well-respected and experienced in the healthcare industry. At SurgLine our mission is to sell the highest quality surgical products at the lowest possible cost…period. Our signature product line, Surg, is produced by the same manufacturers as other leading medical companies without the brand premium. We are reducing the 'brand premium' much in the same way as Costco has with their Kirkland brand. By removing the brand premium we can pass along cost savings to our customers which include U.S. based distributors and institutions. SurgLine is founded on the premise that the U.S. healthcare system MUST reduce spending and do more with less, thus Surgline offers it's exclusive line of high quality "private labeled" surgical products, under our brand "Surg," for the operating and emergency room at substantial savings of up to 40% when compared to the larger well known legacy medical and surgical suppliers. SurgLine business model focuses on procuring the "Best of Class" products and then distributing these products to hospitals and free standing surgery centers throughout the United States for substantially less money. SURGLINE PRODUCTS! SurgLine has over 20,000 SKUs of FDA approved products. SurgLine's signature product line, Surg, is the value leader and designed to be of equal or better quality than national brands. SurgLine, Inc. offers "more value for less of your healthcare dollar" when compared to the competition. Benefits afforded to our clients who partner with SurgLine include: > Highest quality products for operating rooms, emergency departments and trauma units. Mr. Toland has more than 30 years of healthcare management experience. Mr. Toland started his healthcare career with American Medical International, followed by financial management and corporate business development positions with Summit Health Ltd., OrNda HealthCorp, and Tenet Healthcare and two large not for profit hospital systems located in Southern California. Mr. Toland is a graduate of the University of Southern California with a major in Accounting in 1980. Richard Dutch | President & COO... Mr. Dutch has over 24 years of healthcare industry experience. Mr. Dutch previously was a Corporate Business Manager with the 3M company, for 17 years, responsible for the P/L, growth and management of the west regions Acute Care and Surgery Center business. Most recently, Mr. Dutch was the President at Sterling Medical Products, a national orthopedic distribution company. His areas of expertise are complex healthcare systems, GPO's, new product launches, navigating the challenging Government market, P/L, and client relationships. Mr. Dutch holds an MBA degree, as well as, a BS degree in Health & Medical Science, Six Sigma certification and was instrumental for the launches of three successful start-up companies.
Barry Hollander | Chief Financial Officer... Mr. Hollander has vast public company experience and is currently the CFO of China Nuvo since 2002 and Techs Loanstar, Inc. since February 2010. Mr. Hollander has held various accounting, senior management and executive financial positions. From 1994 to 1999, Mr. Hollander was the CFO of California Pro Sports, Inc., an in-line skate importer, marketer and distributor. Mr. Hollander has a BS degree from Fairleigh Dickinson University.
MORE HUGE NEWS: 09/17/2012 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Charts
_____________________________________________________________________________________________________________________________
CHARTS FOR YOU TECHNICAL PLAYERS!
( 1 month daily, 3 month daily, 1 year weekly)
(3 month daily)
(6 Month Daily w/ ADX,..................................... 6 Month w/ Psar & PPO)
( 1 yr daily , .................................................... 1 yr daily )
1 YR Weekly ,........2 YR Daily
AI
